From: Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis
 | All patients (n = 2,653) | No ICU admission following BMT hospitalization (n = 1,974)a | ICU admission during subsequent hospitalizations (n = 504) | P valueb |
---|---|---|---|---|
Age (standard deviation) at BMT (years) | 44 (12) | 44 (12) | 43 (11) | 0.04 |
Female gender (%) | 1,221(46) | 907 (46) | 217 (43) | 0.24 |
Allogeneic BMT (%) | 1,583(60) | 1,215 (62) | 264 (52) | 0.0002 |
ICU stay during BMT admission (%) | 2,544(96) | 1,877 (95) | 496 (98) | 0.013 |
Mechanical ventilation during BMT admission (%) | 181 (7.1) | 31 (2.0) | 54 (11) | <0.0001 |
Length of hospital stay (standard deviation) during BMT admission (days) | 32 (21) | 31 (20) | 33 (19) | 0.0028 |
Physician claims (standard deviation) during 3 years preceding BMT admission | 151 (83) | 145 (74) | 172 (107) | <0.0001 |
Charlson score > 2 during BMT hospitalization (%) | 150 (5.6) | 128 (6.0) | 12 (2.0) | 0.0004 |
Malignancy | 2,582(97) | 1,920 (97) | 492 (98) | 0.66 |
Leukemia | 948 (36) | 620 (31) | 227 (45) | <0.0001c |
Lymphoma | 831 (31) | 666 (34) | 125 (25) | Â |
Multiple myeloma | 461 (17) | 364 (18) | 86 (17) | Â |
Breast cancer | 151 (5.7) | 131 (6.6) | 15 (3.0) | Â |